ML20147F183
| ML20147F183 | |
| Person / Time | |
|---|---|
| Issue date: | 03/03/1997 |
| From: | Trottier C NRC |
| To: | Lohaus P NRC |
| Shared Package | |
| ML20147F155 | List: |
| References | |
| NUDOCS 9703200098 | |
| Download: ML20147F183 (1) | |
Text
. 1 l
i From: Cheryl Trottier To: WND1.WNP9.PHL Date: 3/3/97 7:58am
Subject:
C-14 rulemaking in her vote sheet on the final rule plan addressing the Tri-Med petition, Commissioner Dieus stated that she will need information from the Agreement States before she will vote on the proposed rule. The two questions she wants raised to the Agreement States are:
- 1. What is the position of the Agreement States on the staff's plan to not limit receipt of I the drug to physicians, but to rely on FDA and State Boards of Pharmacy to decide who should administer the drug?
- 2. Are there State requirements mandated >
lulation other than the radiation control program regulations, that might be of conce . ^e capsules are authorized under an exempt distribution license, with a Division 1 avel of compatibility?
We are trying to move forward quickly on this rulemaking and would like to get it to the Commission by the end of March. We are sending it out for office concurrence momentarily (hopefully, Morrison will sign out today). We are giving the offices only 2 weeks to concur, but most likely they will need the full 3 weeks we normally give them.
Anyway, do you have a mechanism to quickly solicit thair views on the proposed rule to satisfy Com Dicus' concerns? I'm attaching the draft FRN so you can mon it to them
- without waiting for the package to arrive from RES.
CC: szj, ant J
A 41
- u! 2pga pag